A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Sarcoma, KaposiHIV Infections
Interventions
DRUG

Doxorubicin hydrochloride (liposomal)

Trial Locations (33)

10011

Saint Vincent's Hosp and Med Ctr, New York

10016

New York Univ Med Ctr, New York

10021

Mem Sloan - Kettering Cancer Ctr, New York

10023

Saint Luke's - Roosevelt Hosp Ctr, New York

10029

Mount Sinai Med Ctr, New York

14263

Roswell Park Cancer Institute, Buffalo

19146

Graduate Hosp / Tuttleman Cancer Ctr, Philadelphia

20037

Dr Mahmoud Mustafa, Washington D.C.

30329

American Med Research Institute, Atlanta

30345

Infectious Disease Rsch Consortium of GA / SE Clin Resources, Atlanta

33136

Univ of Miami School of Medicine, Miami

33612

H Lee Moffit Cancer Ctr and Research Institute, Tampa

48202

Henry Ford Hosp, Detroit

60611

Northwestern Med Faculty Foundation, Chicago

60612

Rush Presbyterian Med College, Chicago

60657

Illinois Masonic Med Ctr / The Cancer Ctr, Chicago

63108

Washington Univ, St Louis

75235

Comprehensive Care Ctr, Dallas

77030

Baylor College of Medicine, Houston

77054

Houston Immunological Institute, Houston

77074

Twelve Oaks Hosp, Houston

90048

Dr Becky Miller, Los Angeles

90211

Pacific Oaks Med Group, Beverly Hills

91403

Pacific Oaks Med Group, Sherman Oaks

91436

Hematology - Oncology Med Group of San Fernando Valley, Encino

92103

Apogee Med Group, San Diego

94110

UCSF - San Francisco Gen Hosp, San Francisco

94115

Kaiser Permanente Med Ctr, San Francisco

94117

UCSF, San Francisco

94121

San Francisco Veterans Administration Med Ctr, San Francisco

94705

East Bay AIDS Ctr, Berkeley

98101

Virginia Mason Research Center / Clinical Trial Unit, Seattle

941430324

UCSF, San Francisco

All Listed Sponsors
lead

Sequus Pharmaceuticals

INDUSTRY